|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4B
|
|
pubmed:dateCreated |
1992-6-5
|
|
pubmed:abstractText |
Fourteen outpatients with mild-to-moderate essential hypertension were treated with perindopril (4-8 mg once daily) for a 16-week period. It was observed that the drug was effective in lowering blood pressure without inducing changes in blood lipids commonly observed with other hypotensive agents. This lipid neutrality, in addition to the lack of side or toxic effects, confers on perindopril a noteworthy therapeutic value in the treatment of essential hypertension.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0002-9343
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
95S-97S
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1580289-Adult,
pubmed-meshheading:1580289-Aged,
pubmed-meshheading:1580289-Analysis of Variance,
pubmed-meshheading:1580289-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:1580289-Blood Glucose,
pubmed-meshheading:1580289-Blood Pressure,
pubmed-meshheading:1580289-Female,
pubmed-meshheading:1580289-Humans,
pubmed-meshheading:1580289-Hypertension,
pubmed-meshheading:1580289-Indoles,
pubmed-meshheading:1580289-Lipoproteins,
pubmed-meshheading:1580289-Male,
pubmed-meshheading:1580289-Middle Aged,
pubmed-meshheading:1580289-Perindopril
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Effects of perindopril on carbohydrate and lipoprotein metabolism in essential hypertension.
|
|
pubmed:affiliation |
Department of Internal Medicine, Hospital of Val di Nievole, Pescia, Italy.
|
|
pubmed:publicationType |
Journal Article
|
